Printer Friendly

MARKET INTELLIGENCE: NEW TECHNOLOGIES, COST-CONTAINMENT SPUR HOME MONITORING MARKETS, TO NEAR $2 BILLION BY 1999

 MOUNTAIN VIEW, Calif., Feb. 12 /PRNewswire/ -- Spurred by new technologies and paced by circulatory system monitors, U.S. home diagnostic and monitoring manufacturer revenues will more than double from $783 million in 1992 to $1.9 billion in 1999, growing at a 13.6 percent compound annual rate, projects a new study just issued by Market Intelligence.
 Cholesterol and blood pressure monitors will lead the market, their share of total sales swelling from 9 percent in 1992 to 14 in 1998, while already well-established pregnancy and ovulation test kits decline in share from 22 to 16 percent in the same period, forecasts the report, "Home Diagnostic and Monitoring Market."
 The largest share of market revenues will continue to come from diabetic monitoring, 57 percent of manufacturer sales in 1992, a figure that will increase even further late in the decade. New substance abuse test kits, a segment projected to emerge in 1994, will remain under 1 percent of the total market through the decade. Test kit vendors are poised for FDA approval within a year.
 Thermometers and other temperature monitors, as well as fecal occult blood tests -- the only monitoring segment not accessible over-the-counter -- will remain relatively stable in shares, declining slightly from current positions, respectively, of 5 and 7 percent of overall market sales.
 Total home diagnostic and monitoring market revenue growth will peak at 16 percent in 1994, and accelerate again at the end of the decade.
 The general escalation of healthcare and insurance costs and the broad-based push for medical cost-containment will motivate more individuals toward monitoring conditions and conducting health tests at home. New technologies and changing social attitudes as well as cost-containment pressures will increase demand for safe, workable and accurate home testing products, giving the diagnostic and monitoring market enormous potential for expansion into new segments.
 Crucial new technologies will include monoclonal antibodies, which have improved accuracy and ease of use of many chemical tests; noninvasive near-infrared spectroscopy, which promises bloodless blood tests, and digital electronic products. Digital technology is only now starting to make headway in home monitoring markets.
 Each year manufacturers scramble to introduce new competitive home products, often successfully converting formerly professional devices. Emerging manufacturers will market and distribute aggressively and introduce new easy-to-use products at affordable prices, hoping to emulate the success of home diabetic glucose monitoring and pregnancy and ovulation test kit vendors, who have penetrated end-user groups extensively with educational and promotional campaigns.
 Vendors will analyze which markets hold the most immediate promise due to pre-existing consumer demand or a level of awareness and concern stimulated by governmental or other educational efforts.
 Small research and development firms are aligning with large marketers to help distribute their newer products. Successful manufacturers will need to make the best use of distribution channels to ensure market coverage in both maturing and emergent subsegments.
 Important recent product developments include new "in-the-ear" thermometers, the growth of digital products within both thermometer and blood pressure markets, positive responses from doctors and distributors to new alternative fecal blood tests, the emergence of blood glucose strips that took market share from established market leaders, as well as fierce competition in the pregnancy and ovulation segment that forced manufacturers to push new "latest-generation" products to keep share.
 Market Intelligence is an international high-technology research firm specializing in healthcare markets. All Market Intelligence reports are based on extensive interviews with marketing and technical experts from selected companies in each market segment. Primary research is validated by thorough analysis of available secondary research. Since 1982, Market Intelligence has emerged as one of the leading publishers of high-technology market research reports.
 MARKET INTELLIGENCE
 Total Home Diagnostic and Monitoring Product Market:
 Revenue Forecasts (U.S.), 1989-1999
 Revenues Revenue Growth Rate
 ($ Million) (Percent)
 1989 545.7 ---
 1990 616.3 12.9
 1991 695.0 12.8
 1992 783.0 12.7
 1993 881.0 12.5
 1994 1,021.4 15.9
 1995 1,151.7 12.8
 1996 1,300.4 12.9
 1997 1,472.0 13.2
 1998 1,675.4 13.8
 1999 1,910.4 14.0
 Compound Annual Growth Rate (1992-1999): 13.6 percent
 -0- 2/12/93
 /CONTACT: Amy Arnell of Market Intelligence, 415-961-9000/


CO: Market Intelligence ST: California IN: CPR HEA SU: ECO

TM-TB -- SJ002 -- 6119 02/12/93 11:32 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 12, 1993
Words:718
Previous Article:WEST COAST BANCORP REPORTS FOURTH QUARTER RESULTS AND RESTRUCTURING
Next Article:$200 MILLION FLORIDA BANK HOLDING COMPANY SIGNS DEFINITIVE AGREEMENT FOR PROPOSED MERGER WITH COMMAND CREDIT CORPORATION
Topics:


Related Articles
MARKET INTELLIGENCE: WORLD MICROMACHINE, MICROSTRUCTURE MARKETS TO TRIPLE, APPROACH $3 BILLION BY 1998
MARKET INTELLIGENCE: WORLD MULTIMEDIA MARKETS TO QUINTUPLE, APPROACH $25 BILLION BY 1998, AS PRICES DROP
'INFOTAINMENT,' EDUCATION, PUBLISHING TO PACE QUINTUPLING WORLD MULTIMEDIA MARKETS
SAFETY MONITOR & DEVICE MARKET TO NEAR $8 BILLION BY 1998, GROW AT 11 PERCENT
MARKET INTELLIGENCE: INTENSIFIED REGULATION, PORTABILITY, TO DOUBLE WASTEWATER ANALYSIS MARKET, APPROACHING $900 MILLION
SYSTEMS INTEGRATION/OUTSOURCING MARKETS TO TRIPLE, PASS $100 BILLION BY 1999
$8 BILLION 800 MARKET TO GROW FIVE PERCENT AS TOLL-FREE NUMBERS GO 'PORTABLE'
APREX TO RECEIVE $2 MILLION FROM PFIZER TO DEVELOP PATIENT COMPLIANCE PROGRAMS
CARDIODYNAMICS SELLS 2ND CARDIAC MONITORING SYSTEM TO NASA.
Bies addresses challenges in retirement savings.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters